Uniphar (LON:UPR) Hits New 1-Year High – Here’s Why

Uniphar plc (LON:UPR) shares hit a new 52-week high during trading on Monday . The stock traded as high as GBX 284 ($3.78) and last traded at GBX 279.09 ($3.71), with a volume of 1825 shares traded. The stock had previously closed at GBX 280 ($3.73).

Analysts Set New Price Targets

Separately, Shore Capital reaffirmed a “buy” rating on shares of Uniphar in a research report on Tuesday, February 25th.

Uniphar Stock Performance

The firm has a market cap of £858.83 million, a price-to-earnings ratio of 19.18 and a beta of 0.75. The firm’s 50 day moving average price is GBX 235.70 and its 200-day moving average price is GBX 203.07. The company has a debt-to-equity ratio of 119.48, a current ratio of 0.90 and a quick ratio of 0.60.

Uniphar Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 16th. Investors of record on Thursday, April 24th will be paid a €0.01 ($0.01) dividend. This represents a dividend yield of 0.47%. This is a positive change from Uniphar’s previous dividend of $0.01. The ex-dividend date of this dividend is Thursday, April 24th. Uniphar’s dividend payout ratio is presently 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.